ARDELYX, INC.

ARDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $120.9M $94.5M $125.2M $110.3M $97.7M $74.1M $116.1M $98.2M
Cost of Revenue $5.8M $4.8M $10.8M $4.0M $12.4M $12.3M $18.3M $15.7M
Gross Profit $115.1M $89.7M $114.4M $106.3M $85.3M $61.8M $97.9M $82.5M
Gross Margin 95.2% 94.9% 91.3% 96.4% 87.3% 83.4% 84.3% 84.0%
Operating Expenses
Research & Development $26.1M $20.2M $22.9M $18.1M $15.7M $14.9M $13.7M $15.3M
SG&A Expense $101.4M $102.3M $86.4M $83.6M $84.0M $83.2M $76.1M $65.0M
Operating Income $-12.4M $-32.8M $5.1M $4.7M $-14.4M $-36.3M $8.1M $2.2M
Operating Margin -10.3% -34.7% 4.1% 4.2% -14.7% -49.0% 7.0% 2.3%
Interest Expense — — — — — — — —
Pretax Income $-16.6M $-37.6M $-400.0K $-867.0K $-19.1M $-40.3M $4.7M $-766.0K
Income Tax Expense $110.0K $8.0K $7.0K $102.0K $1.0K $859.0K $35.0K $43.0K
Net Income $-16.7M $-37.6M $-407.0K $-969.0K $-19.1M $-41.1M $4.6M $-809.0K
Net Margin -13.8% -39.8% -0.3% -0.9% -19.5% -55.5% 4.0% -0.8%
EPS (Basic) $-0.07 $-0.15 $-0.01 $0.00 $-0.08 $-0.17 $0.01 $0.00
EPS (Diluted) $-0.07 $-0.15 $-0.01 $0.00 $-0.08 $-0.17 $0.01 $0.00
Shares Outstanding (Basic) 248.1M 245.9M 241.0M 241.9M 239.9M 238.6M 235.2M 235.9M
Shares Outstanding (Diluted) 248.1M 245.9M 241.0M 241.9M 239.9M 238.6M 235.2M 235.9M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →